Is AtaiBeckley Inc. (ATAI) Stock a Psychedelic Medicine Opportunity Ahead of Phase 2 Results?
TheFly reported on July 7 that Canaccord increased its price target on ATAI to $17 from $15 while maintaining a Buy rating on the shares.
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| | $4.96 | 100,000 | $496,000.00 | 100,000 | 2026-07-07 | Filing |
| | $4.51 | 42,579 | $192,031.29 | 8,437 | 2026-06-25 | Filing |
| | $5.00 | 50,000 | $250,000.00 | 0 | 2026-06-26 | Filing |
| | $5.00 | 42,579 | $212,895.00 | 8,437 | 2026-04-20 | Filing |
| | $3.55 | 100,000 | $355,000.00 | 8,437 | 2026-03-20 | Filing |
July 15th, 2026 - News
July 15th, 2026 - Hedge Funds News
July 13th, 2026 - Hedge Funds News
June 16th, 2026 - Hedge Funds News
June 15th, 2026 - Hedge Funds News
June 12th, 2026 - Hedge Funds News
June 5th, 2026 - Hedge Funds News
June 4th, 2026 - Hedge Funds News
May 20th, 2026 - Hedge Funds News
May 8th, 2026 - Hedge Funds News
Returns since its inception in May 2014 (through June 2, 2026)
Subscribe Now30 day money back guarantee. Cancel anytime.